> navigate:  
  Academic Programs

Xinyu (Eric) Wang, PhD

Xinyu (Eric) Wang, PhD

Assistant Professor of Pharmaceutical Sciences

Contact
Ph: 678-407-7344
FX: 678-407-7347
E-mail: xinyuwa@pcom.edu

Education

PhD in Pharmaceutical Sciences, University of Texas at Austin, 2008
BS in Pharmacy, Peking University Health Science Center, China, 1997

Narrative

As an educator for PharmD students, Dr. Wang is dedicated to facilitating student learning and promoting student professional development. He has taught different topics in pharmaceutical sciences including Pharmaceutics, Pharmaceutics Labs, Biopharmaceutics, Pharmacokinetics, and Pharmaceutical Calculations. He incorporates various strategies of active learning in every course he teaches. He also mentors students to present research work in local and national scientific meetings. 
 
Dr. Wang’s research interest is focused on drug discovery and development to identify potential drug candidates with anti-cancer, anti-inflammatory, and anti-oxidant properties. He has presented his research in various national and international conferences and published peer-reviewed articles in different pharmaceutical fields including medicinal chemistry, molecular pharmacology, pharmaceutical analysis, and pharmacokinetics.
 
Dr. Wang appreciates a balance of life. In his spare time, he enjoys a variety of activity in sports such as basketball, badminton, table tennis, and swimming. He is also interested in playing billiards and golf these days. He is a member of PCOM School of Pharmacy bowling league. 
 

Honors/Awards

Peach Award in Teaching, PCOM School of Pharmacy, 2012 - 2013
Peach Award in Teaching, PCOM School of Pharmacy, 2011 - 2012
Sigma Xi, the Scientific Research Society
Phi Kappa Phi honor society
Rho Chi honor society in pharmacy

Selected Publications

 

Wang X, Stavchansky S, Kerwin SM, Bowman PD. Structure-activity relationships in the cytoprotective effect of caffeic acid phenethyl ester (CAPE) and fluorinated derivatives: Effects on heme oxygenase-1 induction and antioxidant activities. European Journal of Pharmacology 2010; 635(1-3): 16-22.

Wang X, Pang J, Maffucci JA, Pade D, Newman RA, Kerwin SM, Bowman PD, Stavchansky S. Pharmacokinetics of caffeic acid phenethyl ester and its fluorinated derivative in rats. Biopharmaceutics & Drug Disposition 2009; 30(5): 221-228.

Wang X, Stavchansky S, Zhao B, Bynum JA, Kerwin SM, Bowman PD. Cytoprotection of human endothelial cells from menadione cytotoxicity by caffeic acid phenethyl ester: The role of heme oxygenase-1. European Journal of Pharmacology 2008; 591(1-3): 28-35.

Wang X, Pang J, Newman RA, Kerwin SM, Bowman PD, Stavchansky S. Quantitative determination of fluorinated caffeic acid phenethyl ester derivative from rat blood plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. Journal of Chromatography B 2008; 867(1): 138-143.

Wang X, Bowman PD, Kerwin SM, Stavchansky S. Stability of caffeic acid phenethyl ester and its fluorinated derivative in rat plasma. Biomedical Chromatography 2007; 21(4): 343-350.

Wang X, Stavchansky S, Bowman PD, Kerwin SM. Cytoprotective effect of caffeic acid phenethyl ester (CAPE) and catechol ring-fluorinated CAPE derivatives against menadione-induced oxidative stress in human endothelial cells. Bioorganic &Medicinal Chemistry 2006; 14(14): 4879-4887.

Selected Presentations

Wang X, Bozman M, Bowman PD, Stavchansky S. Cytotoxicity of caffeic acid phenethyl ester (CAPE) in human multiple myeloma cells: the involvement of oxidative stress and inflammatory response, American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, November 2013.

Wang X, Li M, Nimmanapalli R, Stavchansky S. Structure/cytotoxicity relationships of caffeic acid phenethyl ester (CAPE) and derivatives in human multiple myeloma cells, American Association of Pharmaceutical Scientists Annual Meeting, Chicago, October 2012.

Wang X, Bowman PD, Stavchansky S. Cytoprotection of human endothelial cells against menadione-induced oxidative stress by CDDO-Imidazolide: a time course study and gene regulatory network analysis, American Association of Pharmaceutical Scientists Annual Meeting, Chicago, October 2012.

Wang X, Stavchansky S, Kerwin SM, Bowman PD. The structure/activity relationship of caffeic acid phenethyl ester (CAPE) and derivatives in protecting human endothelial cells against oxidative stress: A gene regulatory network analysis, American Association of Pharmaceutical Scientists Annual Meeting, Washington DC, October 2011.

Grants

Wang X., Principal Investigator. Identification of potential drug candidates for ameliorating oxidative stress involved ischemia reperfusion injury, CCDA Grant, 2011 –2012.
 
Wang X., Principal Investigator. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on multiple myeloma cell growth, CCDA Grant, 2012 –2013.
 
Wang X., Principal Investigator. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on multiple myeloma cell growth: Nrf2 and NF-kB crosstalk, CCDA Grant, 2013 –2014.

 

Last Updated: 4/16/15